Most Recent
The NSW Court of Appeal has struck down a law passed in the wake of the Bondi massacre that barred protest after a terrorist incident, finding it unconstitutional.
Australia's richest person Gina Rinehart could be on the hook for millions of dollars in royalty payments, in a long-running battle over lucrative iron ore mining tenements in Western Australia's Pilbara region.
Construction PRO
Mining magnate Gina Rinehart is on the hook for royalties payable to the heirs of iron ore pioneers Don Rhodes and Peter Wright, a judge has held in a long-running battle over lucrative tenements in the Pilbara region.
US-based drug maker Cosette has lost its bid to stay proceedings alleging it induced the treasurer to reject its $672 million tie-up with Mayne Pharma, with a judge finding Mayne has a right to prosecute its case and would be prejudiced by the delay.
A judge has refused to disqualify himself from case managing Mayne Pharma's latest dispute with US drug maker Cosette over the collapse of their $672 million merger agreement, calling the bid “plainly premature”.
Collapsed supply chain finance company Greensill Bank can't access a copy of a Tokio Marine unit's database, with a judge finding the copy was created for the primary purpose of HWL Ebsworth providing legal advice.
A SkyCity shareholder has lost his bid to bring a case against former executives and directors at the ASX-listed casino seeking to recoup a $67 million penalty over breaches of money laundering regulations.
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
London City Equities has reached a settlement with listed firm Excelsior in a case alleging shareholder oppression over a decision to sell off a subsidiary for $101 million and not distribute the proceeds.
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.